ALMR Alamar Biosciences, Inc.

ALMR Alamar Biosciences, Inc.

Healthcare · Medical Devices

Market read

POC $24.47 · VWAP $27.48 · -8.0% vs 12m avg buyer

too-young gaps: overnight-shiftchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

1 watchlist

ALMR Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist ALMR belongs to, members best 30-day change first — ALMR highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Next earnings ALMR reports in 17 days Nov 3

Last report Aug 10

Alamar Biosciences furnished its earnings release to the SEC on August 10, 2026 (8-K, Item 2.02) and filed its 10-Q for the quarter ended June 30, 2026 on August 11, 2026. Its 10-Q reports (GAAP): revenue $29M, diluted EPS -$0.22, net income -$13M.

full note →

Against street estimates

How ALMR's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

1 quarter on file · newest report Aug 10 · projection Oct 16

Result
Aug 10 -0.32-0.20+37.4%Beat

Recent news

Headlines about ALMR from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 10 days ago · Oct 7

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.

Types